Last Update Time:
20-Mar-2025 14:40:24
ISIN:
INE0DK501011
Sector:
Healthcare
Symbol:
PPLPHARMA
Piramal Pharma Limited
₹221.00
₹2.50
(1.14%)
▲
Prev. Close
₹218.50
Open
₹220.00
Close
₹0.00
Range
₹209.95 - ₹232.05
High
₹223.30
Low
₹217.73
Ind. Close
₹0.00
VWAP
₹220.66
The current stock price of Piramal Pharma Limited is ₹221.00, with a target price range between ₹209.95 and ₹232.05. The stock has experienced a price change of ₹2.50 (1.14%), reflecting recent market volatility.
Today's opening price was ₹220.00, while the previous close stood at ₹218.50.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Piramal Pharma Limited Price Chart
Piramal Pharma Limited Pre Open Market Overview: 20-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 220
- Previous Close Price: 218.5
- Change: 1.50%
- Total Traded Volume: 7,078
- Total Buy Quantity: 47,989
- Total Sell Quantity: 105,934
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 218.85 | 500.00 | 0.00 |
| 219.00 | 695.00 | 0.00 |
| 219.20 | 200.00 | 0.00 |
| 219.70 | 1.00 | 0.00 |
| 220.00 | 530.00 | 0.00 |
| 220.10 | 0.00 | 62.00 |
| 220.40 | 0.00 | 4.00 |
| 220.50 | 0.00 | 605.00 |
| 220.75 | 0.00 | 5.00 |
| 220.90 | 0.00 | 500.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 221.00 | 337 | 221.03 | 113 |
| 220.95 | 1 | 221.04 | 254 |
| 220.90 | 3 | 221.05 | 86 |
| 220.89 | 18 | 221.06 | 3 |
| 220.88 | 39 | 221.08 | 17 |
Total Buy Quantity: 47989
Total Sell Quantity: 105934
Shareholding Patterns of Piramal Pharma Limited
Key Trade Statistics of Piramal Pharma Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 25.52 |
| Traded Value (₹ Cr.) | 56.31 |
| Total Market Cap (₹ Cr.) | 29,299.03 |
| Free Float Market Cap (₹ Cr.) | 13,582.38 |
| Impact cost | 0.05 |
| Quantity Traded | 2,399,510.00 |
| Deliverable Quantity | 922,925.00 |
| % of Quantity to Traded | 38.46 |
| Security VaR | 19.02 |
| Index VaR | N/A |
| VaR Margin | 19.02 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 22.52 |
| Face Value | 10 |
Key Price Statistics of Piramal Pharma Limited
The 52-week high for Piramal Pharma Limited was ₹307.90, recorded on 06-Nov-2024. On the other hand, the 52-week low stands at ₹118.25, with the lowest value recorded on 26-Mar-2024.
The upper band for trading is ₹262.20, and the lower band is ₹174.80. The price band is 20%.
The stock's daily volatility stands at 2.91, while the annualized volatility is 55.60. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (06-Nov-2024) | 307.90 |
| 52 Week Low (26-Mar-2024) | 118.25 |
| Upper Band | 262.20 |
| Lower Band | 174.80 |
| Price Band (%) | 20 |
| Daily Volatility | 2.91 |
| Annualised Volatility | 55.60 |
| Tick Size | 0.01 |
Key Securities Statistics of Piramal Pharma Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 19-Oct-2022 |
| Adjusted P/E | 0 |
| Symbol P/E | 0 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Piramal Pharma Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Piramal Pharma Limited
| Subject | Date |
|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 11-Mar-2025 |
| Copy of Newspaper Publication | 20-Feb-2025 |
| Shareholders meeting | 19-Feb-2025 |
| Notice Of Shareholders Meetings-XBRL | 19-Feb-2025 |
| Updates | 19-Feb-2025 |
| General Updates | 18-Feb-2025 |
| General Updates | 18-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 17-Feb-2025 |
Corporate Actions of Piramal Pharma Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Rs 0.11 Per Share | 12-Jul-2024 |
| 10 | Rights 5:46 @ Premium Rs 71/- | 02-Aug-2023 |
Board Meetings of Piramal Pharma Limited
Financial Results of Piramal Pharma Limited
Company Directory of Piramal Pharma Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | Gr. Flr., Piramal Ananta, Agastya Corp. Park, Kamani Jucntion, LBS Marg, kurla | MUMBAI |
| N/A | Registered Office | Gr. Flr., Piramal Ananta, Agastya Corp. Park, Kamani Jucntion, LBS Marg, kurla | MUMBAI |
| N/A | Transfer Agent | C-101, 247 Park LBS Marg Vikhroli | MUMBAI |
Insider Trading of Piramal Pharma Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Piramal Pharma Limited
Investor Complaints of Piramal Pharma Limited
Event Calendar of Piramal Pharma Limited
| Purpose | Details |
|---|---|
| Other business matters | Piramal Pharma Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2022 to consider financial statements for the period ended September 2022. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the period ended June 30, 2024 |
| Financial Results | To consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the period ended June 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Piramal Pharma Limited
Voting Results of Piramal Pharma Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 26-JUL-2024 | AGM | Adoption of the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March31, 2024 and the Reports of the Board of Directors and Auditors thereon. |
| 26-JUL-2024 | AGM | Ratification of remuneration payable to Cost Auditors |
| 26-JUL-2024 | AGM | Issue of Non-Convertible Debentures on Private Placement Basis |
| 26-JUL-2024 | AGM | Payment of Commission to Non-Executive Directors of the Company |
| 26-JUL-2024 | AGM | Re-appointment of Mr. Vivek Valsaraj as Executive Director of the Company |
| 26-JUL-2024 | AGM | Re-appointment of Mr. Vivek Valsaraj (DIN: 06970246), who retires by rotation and being eligible, offers himself for re-appointment. |
| 26-JUL-2024 | AGM | Declaration of final dividend on equity shares for the financial year ended March 31, 2024. |
| 31-JUL-2023 | AGM | Adoption of Audited Financial Statements (Standalone and Consolidated) and the Reports of the Board of Directors and Auditors thereon of the Company for the financial year ended on March 31, 2023 |
| 31-JUL-2023 | AGM | Ratification of remuneration payable to Cost Auditors |
| 31-JUL-2023 | AGM | Issue of Non-Convertible Debentures on Private Placement Basis |
| 31-JUL-2023 | AGM | Amendment of Articles of Association of the Company |
| 31-JUL-2023 | AGM | Re-appointment of Ms. Nandini Piramal as Chairperson of the Company |
| 31-JUL-2023 | AGM | Re-appointment of Mr. Peter DeYoung as Executive Director of the Company. |
| 31-JUL-2023 | AGM | Re-appointment of Mr. Neeraj Bhardwaj, who retires by rotation and being eligible, seeks reappointment |
| 20-MAR-2023 | Postal Ballot | 1 - Ratification of the Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022. |
| 20-MAR-2023 | Postal Ballot | 2 - Ratification of the extension of the benefits under the Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022 to the employees of holding, subsidiary companies and group companies of the Company. |
| 20-MAR-2023 | Postal Ballot | 3 - Ratification for implementation of the Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022 through trust route. |
| 20-MAR-2023 | Postal Ballot | 4 - Ratification for acquisition of shares of the Company by the Trust for the purposes of Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022. |
| 20-MAR-2023 | Postal Ballot | 5 - Ratification of the approval on granting loan and/ or providing guarantee or security for purchase of the shares of the Company by the Trust / Trustees of the Trust for the benefit of the employees under the Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022. |
FAQs on Piramal Pharma Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.